NewsRx

Search our medical news database

Cancer

Promising Cancer Therapeutics Developed by SRI International

Published in Healthcare Mergers, Acquisitions and Ventures Week, June 23rd, 2007

SRI International, an independent nonprofit research and development organization, announced the continued progress of several compounds that show promise as therapeutics against cancer. SRI executives will be on hand at the 2007 meeting of the American Society of Clinical Oncology (ASCO) to discuss potential partnerships for further development of these anticancer agents.

"For more than half a century, SRI has conducted basic and applied research in the discovery and development of new drugs. With three drugs on the market, four in various stages of clinical trials and five lead compounds in preclinical development, our success is clearly demonstrated by our pipeline,"...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook